SB 1214 Arizona Senate · 57th Legislature - First Regular Session

pharmacists; independent testing; treatment

SB 1214 allows Arizona pharmacists to independently order, perform, and interpret specific health tests (like for flu, strep throat, or COVID-19) and initiate treatment for certain conditions without a doctor's direct order, under a statewide protocol approved by the Arizona State Board of Pharmacy. Pharmacists must use federally approved tests, follow evidence-based guidelines (like CDC recommendations), refer patients to primary care providers if treatment fails or isn't suitable, and notify primary care providers within 72 hours of treatment. The bill requires pharmacists to maintain detailed records for seven years, prohibit opioid treatments, obtain parental consent for minors, and inform patients that care is provided without physician oversight - recommending follow-up with a primary care provider.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
Senate Passage
Mar 2025
House Passage
Governor
Introduced Jan 27, 2025 Last action Apr 15, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Version Senate Engrossed Version · 4 edits · Mar 3, 2025
MODERATE
This bill was amended to clarify and expand the scope of pharmacists' independent testing and treatment authority in Arizona. The primary changes include raising the minimum age for eligible patients from six to twelve years, adding SARS-CoV-2 and other coronavirus respiratory illnesses to the list of treatable conditions, and updating the committee composition requirements for the advisory committee that will oversee protocol development.
Scope change
The bill's scope was expanded to include coronavirus respiratory illnesses and the age eligibility threshold was increased, making the program applicable to older children and adolescents while broadening the range of conditions pharmacists can address independently.
ELIGIBILITY

The minimum age for patients eligible for pharmacist-initiated testing and treatment was increased from six years to twelve years.

SCOPE

SARS-CoV-2 and other coronavirus respiratory illnesses were added to the list of health conditions pharmacists can independently treat.

REQUIREMENT

The advisory committee composition requirements were updated to specify two physicians specializing in primary care instead of one, and to clarify the language regarding physician specialization and patient demographics.

TECHNICAL

Several formatting and capitalization inconsistencies were corrected throughout the text, including standardizing capitalization of medical terms and section headers.

Floor votes · Senate Mar 3, 2025

How they voted

227
Passed · 1 other
Total votes 30
Mar 3, 2025
D Democratic13
8 Yea 4 Nay 1
61% Yea
R Republican17
14 Yea 3 Nay
82% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
11
Key actions
5
Committee
1
Amendments
2
Apr 15, 2025
Lower · Passed
DP
lower
Mar 17, 2025
Lower · Passed
DP
lower
Mar 3, 2025
Upper · Passed
PASSED
upper
Feb 27, 2025
Upper · Passed
DPA
upper
Feb 5, 2025
Upper · Passed
DPA
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of T.J. Shope
T.J. Shope
RRepublican
AZ
16